These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6450251)

  • 21. Phage neutralization by sera of patients receiving phage therapy.
    Łusiak-Szelachowska M; Zaczek M; Weber-Dąbrowska B; Międzybrodzki R; Kłak M; Fortuna W; Letkiewicz S; Rogóż P; Szufnarowski K; Jończyk-Matysiak E; Owczarek B; Górski A
    Viral Immunol; 2014 Aug; 27(6):295-304. PubMed ID: 24893003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs.
    Böttger EC; Hoffmann T; Hadding U; Bitter-Suermann D
    J Immunol; 1985 Dec; 135(6):4100-7. PubMed ID: 2933459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity for tail fibers of a humoral crab factor neutralizing T2 bacteriophage.
    Donnelly C; Clem LW
    Dev Comp Immunol; 1982; 6(1):171-4. PubMed ID: 7067888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Affinity ranking of antibodies using flow cytometry: application in antibody phage display-based target discovery.
    Geuijen CA; Clijsters-van der Horst M; Cox F; Rood PM; Throsby M; Jongeneelen MA; Backus HH; van Deventer E; Kruisbeek AM; Goudsmit J; de Kruif J
    J Immunol Methods; 2005 Jul; 302(1-2):68-77. PubMed ID: 15992810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of genetically engineered M13K07 helper phage for simultaneous phage display of gold binding peptide 1 and nuclear matrix protein 22 ScFv antibody.
    Fatemi F; Amini SM; Kharrazi S; Rasaee MJ; Mazlomi MA; Asadi-Ghalehni M; Rajabibazl M; Sadroddiny E
    Colloids Surf B Biointerfaces; 2017 Nov; 159():770-780. PubMed ID: 28886513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preparation of human phage antibodies specific for SSA/Ro antigen and its sequence analysis].
    Li YJ; Peng JM; Zhang FC
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1904-8. PubMed ID: 15631804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and Level Evaluation of Antibodies Specific to Environmental Bacteriophage I11mO19 and Related Coliphages in Non-Immunized Human Sera.
    Brzozowska E; Lipiński T; Korzeniowska-Kowal A; Filik K; Górski A; Gamian A
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antistaphylococcal antibodies that intensify the action of staphylococcal phage].
    Sachkov VI; Moskvina EM
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Dec; (12):72-5. PubMed ID: 4281598
    [No Abstract]   [Full Text] [Related]  

  • 29. Suppressor T cells in low zone tolerance. I. Mode of action of suppressor cells.
    Stumpf R; Heuer J; Kölsch E
    Eur J Immunol; 1977 Feb; 7(2):74-85. PubMed ID: 301473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological properties of hyaluronidases associated with temperate bacteriophages of group A streptococci.
    Benchetrit LC; Wannamaker LW; Gray ED
    J Exp Med; 1979 Jan; 149(1):73-83. PubMed ID: 368286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sh. dysenteriae serotypes2,4,8-immunochemistry and phage receptor activity.
    Goldhar J; Barber C; Eylan E
    Zentralbl Bakteriol Orig A; 1976 Oct; 236(1):89-98. PubMed ID: 63197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of dairy bacteriophages by commercial sanitizers and disinfectants.
    Campagna C; Villion M; Labrie SJ; Duchaine C; Moineau S
    Int J Food Microbiol; 2014 Feb; 171():41-7. PubMed ID: 24321601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of low temperatures of the survival and intracellular multiplication of Escherichia coli bacteriophages].
    Tsutsaeva AA; Bysekantsev IP; Mikulinskiĭ IuE; Butenko AE
    Mikrobiologiia; 1981; 50(2):292-4. PubMed ID: 6454057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phage antibodies: will new 'coliclonal' antibodies replace monoclonal antibodies?
    Chiswell DJ; McCafferty J
    Trends Biotechnol; 1992 Mar; 10(3):80-4. PubMed ID: 1367944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient in vitro affinity maturation of phage antibodies using BIAcore guided selections.
    Schier R; Marks JD
    Hum Antibodies Hybridomas; 1996; 7(3):97-105. PubMed ID: 9057057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on bacteriophages of hemolytic streptococci. I. Factors influencing the interaction of phage and susceptible host cell.
    KRAUSE RM
    J Exp Med; 1957 Sep; 106(3):365-84. PubMed ID: 13463248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of phage-displayed recombinant anti-idiotypic antibody fragments against coronavirus-neutralizing monoclonal antibodies.
    Lamarre A; Talbot PJ
    Viral Immunol; 1997; 10(4):175-82. PubMed ID: 9473148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of adhesion molecules in the regulation of antibody responses.
    Ochs HD; Nonoyama S; Farrington ML; Fischer SH; Aruffo A
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):72-9; discussion 80-1. PubMed ID: 8303313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced Analysis to Distinguish between Physical Decrease and Inactivation of Viable Phages in Aerosol by Quantitating Phage-Specific Particles.
    Shimasaki N; Nojima Y; Sakakibara M; Kikuno R; Iizuka C; Okaue A; Okuda S; Shinohara K
    Biocontrol Sci; 2018; 23(1):7-15. PubMed ID: 29576594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ambivalent bacteriophages of different species active on Escherichia coli K12 and Salmonella sps. strains].
    Krylov VN; Miller S; Rachel R; Biebl M; Pletneva EA; Shuetz M; Krylov SV; Shaburova OV
    Genetika; 2006 Feb; 42(2):159-68. PubMed ID: 16583699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.